228 related articles for article (PubMed ID: 13499)
21. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
[No Abstract] [Full Text] [Related]
22. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase.
Hervé D; Lévi-Strauss M; Marey-Semper I; Verney C; Tassin JP; Glowinski J; Girault JA
J Neurosci; 1993 May; 13(5):2237-48. PubMed ID: 8478697
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.
Mishra RK; Gardner EL; Katzman R; Makman MH
Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3883-7. PubMed ID: 4372596
[TBL] [Abstract][Full Text] [Related]
24. A dopamine-stimulated adenylate cyclase in rat substantia nigra.
Spano PF; Di Chiara G; Tonon GC; Trabucchi M
J Neurochem; 1976 Dec; 27(6):1565-8. PubMed ID: 1003232
[No Abstract] [Full Text] [Related]
25. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
[No Abstract] [Full Text] [Related]
26. The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivity.
Parenti M; Gentleman S; Olianas MC; Neff NH
Neurochem Res; 1982 Jan; 7(1):115-24. PubMed ID: 7070577
[TBL] [Abstract][Full Text] [Related]
27. Activation of the nigrostriatal dopaminergic pathway by injection of cholera enterotoxin into the substantia nigra.
Quenzer LF; Galli CL; Neff NH
Science; 1977 Jan; 195(4273):78-80. PubMed ID: 831258
[TBL] [Abstract][Full Text] [Related]
28. GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol.
Gale KN; Guidotti A
Nature; 1976 Oct; 263(5579):691-3. PubMed ID: 10528
[No Abstract] [Full Text] [Related]
29. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
Hefti F; Melamed E; Wurtman RJ
Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003
[TBL] [Abstract][Full Text] [Related]
30. Endogenous components of the striatum confer dopamine-sensitivity upon adenylate cyclase activity: the role of endogenous guanyl nucleotides.
Chen TC; Cote TE; Kebabian JW
Brain Res; 1980 Jan; 181(1):139-49. PubMed ID: 7350949
[TBL] [Abstract][Full Text] [Related]
31. Evidence that [3H]forskolin binding in the substantia nigra is intrinsic to a striatal-nigral projection: an autoradiographic study of rat brain.
Gehlert DR; Dawson TM; Filloux FM; Sanna E; Hanbauer I; Wamsley JK
Neurosci Lett; 1987 Jan; 73(2):114-8. PubMed ID: 3822243
[TBL] [Abstract][Full Text] [Related]
32. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
33. Absence of dopamine sensitive adenylate cyclase in the A10 region, the origin of mesolimbic dopamine neurones.
Lorez HP; Burkard WP
Experientia; 1979 Jun; 35(6):744-6. PubMed ID: 223873
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
Gale K; Costa E; Toffano G; Hong JS; Guidotti A
J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
[No Abstract] [Full Text] [Related]
35. GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways.
Ribak CE; Vaughn JE; Roberts E
Brain Res; 1980 Jun; 192(2):413-20. PubMed ID: 7378797
[TBL] [Abstract][Full Text] [Related]
36. [3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.
Cross AJ; Waddington JL
Neurosci Lett; 1980 May; 17(3):271-5. PubMed ID: 6302586
[TBL] [Abstract][Full Text] [Related]
37. Dopamine receptor sensitivity in brain and retina of rats during aging.
Govoni S; Loddo P; Spano PF; Trabucchi M
Brain Res; 1977 Dec; 138(3):565-70. PubMed ID: 597726
[No Abstract] [Full Text] [Related]
38. Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum.
Olianas MC; Onali P; Neff NH; Costa E
J Neurochem; 1983 Nov; 41(5):1364-9. PubMed ID: 6619871
[TBL] [Abstract][Full Text] [Related]
39. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
Cruz CJ; Beckstead RM
Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
[TBL] [Abstract][Full Text] [Related]
40. Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
Zivkovic B; Oblin A; Bartholini G
Eur J Pharmacol; 1985 Jun; 112(2):253-5. PubMed ID: 2411575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
